Pancreatic cancer is the third leading cause of cancer-related deaths in the United States, with a five-year survival rate of 13%. Survival remains low in part because most patients are […]
Dr. Evan Abt: Advancing Immuno-Metabolic Therapies for Pancreatic Cancer
As we celebrate the 20th anniversary of our Seed Grant Program, we’re proud to highlight a new generation of researchers leading the charge to cure pancreatic cancer. Among them is […]
Dr. David Gius: A Leader in Translational Cancer Research
Since 2005, our Seed Grant Program has fostered an environment for research to bloom. As we mark 20 years since our first cohort of grantees, it is more exciting than […]
Progress in Pancreatic Cancer: A 2025 Update from Dr. Timothy Donahue
Each year at our Hirshberg Symposium on Pancreatic Cancer, we share the latest progress in pancreatic cancer research and treatment. At our 2025 Symposium, Dr. Timothy Donahue, Chief of Surgical […]
Empowering Patients with Knowledge: Updated NCCN Guidelines for Pancreatic Cancer Now Available
Receiving a pancreatic cancer diagnosis can be overwhelming, but trusted information can make a meaningful difference. That’s why we’re proud to once again support the NCCN Guidelines for Patients: Pancreatic […]
Dr. Rushika Perera: A Bold Career Fueled by Early Support
Since 2005, our Seed Grant Program has fostered an environment where research can bloom. As we mark 20 years since our first cohort of grantees, it is inspiring to reflect […]